{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02195323",
      "OrgStudyIdInfo": {
        "OrgStudyId": "Royan-Kidney-004"
      },
      "Organization": {
        "OrgFullName": "Royan Institute",
        "OrgClass": "OTHER_GOV"
      },
      "BriefTitle": "Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)",
      "OfficialTitle": "Administration of Autologous Bone Marrow Mesenchymal Stem Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2015",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2014"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2015",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "January 2016",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "July 17, 2014",
      "StudyFirstSubmitQCDate": "July 18, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 21, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "January 3, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 5, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Royan Institute",
        "LeadSponsorClass": "OTHER_GOV"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "This study was designed to provide confirmation of safety of mesenchymal stem cells (MSCs) therapy in chronic kidney disease (CKD).",
      "DetailedDescription": "We will assess the 18-month safety and potential efficacy of autologous MSCs as a therapy for CKD. A total of 10 patients with CKD IV injection of high doses 2Ã—106/kg of autologous MSCs t, which will be derived from biopsies of their bone marrow. Assessments will be performed at 1, 3, 6, 12 and 18 months after cell injection. Changes in Glomerular Filtration Rate (GFR) were evaluated by scan isotope."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Chronic Kidney Disease"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "autologous bone marrow mesenchymal stem cells chronic kidney disease"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "7",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MSC recipient",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "The patients with CKD who underwent intravenous injection of MSC.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Intravenous injection"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Intravenous injection",
            "InterventionDescription": "Intravenous injection of bone marrow derived MSC in patients with CKD.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSC recipient"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Intravenous transplantation"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "mass formation",
            "PrimaryOutcomeDescription": "Evaluation the probability of mass formation due to MSC transplantation 6 months after cell injection.",
            "PrimaryOutcomeTimeFrame": "6months"
          },
          {
            "PrimaryOutcomeMeasure": "Creatinin",
            "PrimaryOutcomeDescription": "Evaluation the rise of creatinin 1 month after cell transplantation.",
            "PrimaryOutcomeTimeFrame": "1 month"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "GFR",
            "SecondaryOutcomeDescription": "Evaluation the increase of GFR 6 months after cell transplantation with scan isotope .",
            "SecondaryOutcomeTimeFrame": "6months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale and Female\nCKD symptoms\nCKD confirmed with serum and urine analysis and GFR 25-60 mL/min/1.73 m2\nPatient's age between 25 - 60 years\nAbility to understand and willingness to sign consent from\n\nExclusion Criteria:\n\nPregnant or lactating\nBasis disease such as diabetes, malignancy and autoimmune\nUnable to follow post-operative exercise regimen or return for evaluations",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "25 Years",
      "MaximumAge": "60 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Hamid Gourabi, PhD",
            "OverallOfficialAffiliation": "Head of Royan Institute",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Nasser Aghdami, MD,PhD",
            "OverallOfficialAffiliation": "Head of regenerative medicine department &cell therapy center of Royan Institute",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Atieh Makhloogh, MD",
            "OverallOfficialAffiliation": "Mazandaran University of Medical Sciences, Mazandaran, Iran",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Reza Moghadasali, PhD",
            "OverallOfficialAffiliation": "Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Royan Institute",
            "LocationCity": "Tehran",
            "LocationCountry": "Iran, Islamic Republic of"
          }
        ]
      }
    },
    "ReferencesModule": {
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Related Info",
            "SeeAlsoLinkURL": "http://Royaninstitute.org"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007674",
            "ConditionMeshTerm": "Kidney Diseases"
          },
          {
            "ConditionMeshId": "D000051436",
            "ConditionMeshTerm": "Renal Insufficiency, Chronic"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000014570",
            "ConditionAncestorTerm": "Urologic Diseases"
          },
          {
            "ConditionAncestorId": "D000051437",
            "ConditionAncestorTerm": "Renal Insufficiency"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9850",
            "ConditionBrowseLeafName": "Kidney Diseases",
            "ConditionBrowseLeafAsFound": "Kidney Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M25871",
            "ConditionBrowseLeafName": "Renal Insufficiency",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25870",
            "ConditionBrowseLeafName": "Renal Insufficiency, Chronic",
            "ConditionBrowseLeafAsFound": "Chronic Kidney Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16471",
            "ConditionBrowseLeafName": "Urologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}